Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Phillips

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|March 8, 2000
Granulocyte-colony stimulating factor (G-CSF)-primed, delayed marrow harvests as a source of hematopoietic stem and progenitor cells for allogeneic transplantationG L Phillips, D D Davey, G A Hale, et al.
Bone Marrow Transplantation|February 1, 1993
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamideD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|January 1, 1995
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantationD E Reece, J D Shepherd, H G Klingemann, et al.
Bone Marrow Transplantation|May 1, 1992
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantationT J Nevill, M H Tirgan, H J Deeg, et al.
Blood|December 15, 1991
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]H G Klingemann, A P Grigg, K Wilkie-Boyd, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Bone Marrow Transplantation|October 21, 2000
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myelomaD E Reece, D A Brockington, G L Phillips, et al.
Medical and Pediatric Oncology|January 1, 1982
Bone marrow transplantation with high-dose cytosine arabinosideR H Herzig, H M Lazarus, J Graham-Pole, et al.
Bone Marrow Transplantation|January 1, 1994
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategiesH G Klingemann, J D Shepherd, D E Reece, et al.
Blood|December 3, 1998
A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host diseaseD Przepiorka, G L Phillips, V Ratanatharathorn, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|March 8, 2000
Granulocyte-colony stimulating factor (G-CSF)-primed, delayed marrow harvests as a source of hematopoietic stem and progenitor cells for allogeneic transplantationG L Phillips, D D Davey, G A Hale, et al.
Bone Marrow Transplantation|February 1, 1993
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamideD E Reece, M J Barnett, J M Connors, et al.
Bone Marrow Transplantation|January 1, 1995
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantationD E Reece, J D Shepherd, H G Klingemann, et al.
Bone Marrow Transplantation|May 1, 1992
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantationT J Nevill, M H Tirgan, H J Deeg, et al.
Blood|December 15, 1991
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]H G Klingemann, A P Grigg, K Wilkie-Boyd, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Bone Marrow Transplantation|October 21, 2000
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myelomaD E Reece, D A Brockington, G L Phillips, et al.
Medical and Pediatric Oncology|January 1, 1982
Bone marrow transplantation with high-dose cytosine arabinosideR H Herzig, H M Lazarus, J Graham-Pole, et al.
Bone Marrow Transplantation|January 1, 1994
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategiesH G Klingemann, J D Shepherd, D E Reece, et al.
Blood|December 3, 1998
A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host diseaseD Przepiorka, G L Phillips, V Ratanatharathorn, et al.
Pageof 16